Literature DB >> 18973738

Advances in the pharmacologic treatment of tension-type headache.

Marcelo E Bigal1, Alan M Rapoport, Richard Hargreaves.   

Abstract

Tension-type headache (TTH) is the most prevalent form of primary headache in the general population. We discuss advances in the treatment of TTH. We briefly review nonpharmacologic therapies and then focus on current pharmacologic strategies. For acute treatment, the most common interventions involve the use of simple analgesics and anti-inflammatory medications, often taken by the patient without a prescription. For preventive treatment, amitriptyline is the best-studied drug, but nortriptyline, mirtazapine, tizanidine, the selective serotonin reuptake inhibitors, and other medications can be used. We close by discussing potential future therapies, including calcitonin gene-related peptide receptor antagonism, as well as substance P and the nitric oxide pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973738     DOI: 10.1007/s11916-008-0075-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  48 in total

1.  Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.

Authors:  S D Silberstein; H Göbel; R Jensen; A H Elkind; R Degryse; J M C M Walcott; C Turkel
Journal:  Cephalalgia       Date:  2006-07       Impact factor: 6.292

Review 2.  Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache.

Authors:  H Vernon; C S McDermaid; C Hagino
Journal:  Complement Ther Med       Date:  1999-09       Impact factor: 2.446

Review 3.  Behavioral headache treatment: history, review of the empirical literature, and methodological critique.

Authors:  Jeanetta C Rains; Donald B Penzien; Douglas C McCrory; Rebecca N Gray
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

4.  2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Authors:  R B Lipton; W F Stewart; R Cady; C Hall; S O'Quinn; T Kuhn; D Gutterman
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

5.  A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.

Authors:  C Lampl; S Marecek; A May; L Bendtsen
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

6.  Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache.

Authors:  C G Dahlöf; L D Jacobs
Journal:  Cephalalgia       Date:  1996-04       Impact factor: 6.292

7.  Physiotherapy for tension-type headache: a controlled study.

Authors:  P Torelli; R Jensen; J Olesen
Journal:  Cephalalgia       Date:  2004-01       Impact factor: 6.292

8.  Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Authors:  Joel R Saper; Alvin E Lake; Deborah T Cantrell; Paul K Winner; Jeffery R White
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

9.  Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M Naumann; Y So; C E Argoff; M K Childers; D D Dykstra; G S Gronseth; B Jabbari; H C Kaufmann; B Schurch; S D Silberstein; D M Simpson
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

10.  Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings.

Authors:  Hartmut Göbel; Vaclav Hamouz; Claudia Hansen; Kurt Heininger; Susanne Hirsch; Volker Lindner; Dieter Heuss; Dieter Soyka
Journal:  Pain       Date:  1994-11       Impact factor: 6.961

View more
  4 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Considerations in the treatment of tension-type headache in the elderly.

Authors:  Stephanie Wrobel Goldberg; Stephen Silberstein; Brian M Grosberg
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 3.  New daily-persistent headache versus tension-type headache.

Authors:  Matthew S Robbins; Sara C Crystal
Journal:  Curr Pain Headache Rep       Date:  2010-12

4.  The adult patient with headache.

Authors:  Vivien Min Er Lee; Lai Lai Ang; Derek Tuck Loong Soon; Jonathan Jia Yuan Ong; Victor Weng Keong Loh
Journal:  Singapore Med J       Date:  2018-08       Impact factor: 1.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.